At-home kits that allow women to collect their own samples for HPV testing have been shown to improve cervical cancer screening rates. But some women lack confidence in their ability to complete the collection themselves.
Rahma Mkuu, Ph.D. Rahma S. Mkuu, Ph.D., answers questions about the first device approved by the FDA for cervical cancer screening. The device from the company Teal Health has an accuracy for detecting human papillomavirus (HPV) that equals tests conducted in a medical office. Nearly all cervical cancers…
Several of our department’s students and faculty members participated in the UF Health Cancer Center’s annual Research Showcase on February 12, 2025. …
A prestigious award of more than $850,000 from the National Cancer Institute will support Rahma Mkuu, PhD, as she builds her expertise in implementation science over the next five years while adressing cervical cancer screening disparities among women living with chronic conditions. Mkuu is an assistant professor and chronic disease researcher in the Department of Health Outcomes & Biomedical Informatics within the University of Florida’s College of Medicine.
The University of Florida Health Cancer Center co-hosted the inaugural Cancer Implementation Science Symposium over two days in June with Mount Kenya University, drawing researchers, faculty, policy advocates, and students.
Two HOBI faculty members received pilot awards from the CTSI Precision Health Initiative this year. Khairul A. Siddiqi, Ph.D., and Rahma S. Mkuu, Ph.D., will leverage big data in the OneFlorida+ Data Trust to identify at-risk women in Florida who could benefit from proven health interventions…
